Antimalarials: Nursing Pharmacology Study Guide

Antimalarial drugs treat and prevent infections caused by Plasmodium parasites. This note reviews the major antimalarials, how they work, their key adverse effects, monitoring needs, and the high-yield safety rules nurses must know for the NCLEX.

Drug Identification Table

• Chloroquine — Malaria treatment; exam clue: drug resistance is common.
• Artemisinin combinations — First-line malaria therapy; exam clue: rapid parasite clearance.
• Mefloquine — Treatment and prophylaxis; exam clue: neuropsychiatric effects.
• Primaquine — Eliminates dormant liver forms; exam clue: prevents relapse.
• Quinine — Severe malaria; exam clue: risk of cinchonism.

Mechanism of Action

• Antimalarials interfere with the life cycle of Plasmodium parasites.
• Some agents target parasites circulating in the bloodstream, while others target parasites that remain dormant in the liver.
• Combination therapy is commonly used to reduce the risk of drug resistance.

Malaria Prophylaxis

• Used to prevent malaria in travelers entering endemic regions.
• Common prophylactic medications:
  • Atovaquone–proguanil
  • Doxycycline
  • Mefloquine
  • Chloroquine
• Prophylaxis is started before entering a malaria-endemic area and continued after leaving the region to ensure full protection.

Indications

Antimalarial drugs are used for both treatment and prevention. Common indications include:

• Acute malaria infection
• Severe malaria
• Malaria prophylaxis for travelers
• Prevention of relapse in Plasmodium vivax and Plasmodium ovale

Primaquine is specifically used to eliminate dormant liver parasites and prevent relapse.

Side Effects

Common side effects include nausea, vomiting, and headache. More serious adverse reactions vary by drug:

• Hemolytic anemia with primaquine in patients with G6PD deficiency
• Neuropsychiatric effects with mefloquine
• Cinchonism with quinine — symptoms include tinnitus, headache, dizziness, and visual disturbances

Labs to Monitor

• Screen for G6PD deficiency before starting primaquine.
• Monitor complete blood count (CBC) during therapy.
• Electrolytes and cardiac monitoring may be required with certain antimalarials.

Contraindications and Cautions

Use antimalarial drugs cautiously in patients with:

• G6PD deficiency
• Cardiac disorders
• Psychiatric disorders

Drug selection should also consider regional resistance patterns.

Pregnancy Safety

• Some antimalarials may be used in pregnancy when benefits outweigh risks.
• Treatment choice depends on the stage of pregnancy and severity of infection.
• Untreated malaria in pregnancy can lead to serious maternal and fetal complications.

Nursing Safety Rules & High-Yield NCLEX Traps

• Travelers must begin prophylaxis before entering malaria-endemic areas.
• Patients must complete the full course of antimalarial therapy even if symptoms improve.
• Patients receiving primaquine must be screened for G6PD deficiency first.
• Early diagnosis and treatment are essential because severe malaria can progress rapidly.
• Common NCLEX traps: ignoring regional drug resistance, missing G6PD testing, and failing to start prophylaxis before travel.

Key Takeaways

• Artemisinin combination therapy is the first-line treatment for active malaria.
• Primaquine eliminates dormant liver parasites and prevents relapse in P. vivax and P. ovale — always screen for G6PD deficiency first.
• Prophylaxis options include atovaquone–proguanil, doxycycline, mefloquine, and chloroquine, started before travel and continued after return.
• Mefloquine → neuropsychiatric effects; quinine → cinchonism (tinnitus, headache, dizziness, visual changes).
• Drug choice depends on regional resistance patterns and patient-specific factors (cardiac, psychiatric, pregnancy).